Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Nov 4 - Nov 9
Following subcutaneous administration in clinical models: Both components demonstrate prolonged absorption with peak plasma concentrations occurring 24-72 hours post-injection GLP3 exhibits approximately 6-day half-life enabling once-weekly dosing Cagrilintide demonstrates 120-165 hour half-life (5-7 days) suitable for weekly administration Lipid conjugation of both peptides enables albumin binding and extended systemic circulation Distribution patterns show systemic exposure with concentration in metabolically active tissues The fatty diacid modifications on both peptides (C20 for GLP3 , eicosanedioic acid for cagrilintide) serve as albumin-binding moieties that dramatically extend plasma residence time compared to native peptides
This bulk kit offers a discounted price compared to purchasing individual vials separately and is ideal for laboratories conducting ongoing research
BPC-157 and Tissue Support One of the most talked-about peptides in this space is BPC-157, which was originally derived from stomach tissue
A review of phytic acid sources, obtention, and applications
In vivo indices of oxidative stress in lead-exposed C57BL/6 mice are reduced by treatment with meso-2,3-dimercaptosuccinic acid or N -acetylcysteine
US$ 20.04
US$ 23.26
US$ 25.56
